NetworkNewsBreaks – AmpliTech Group Inc. (NASDAQ
Post# of 140
(Total Views: 310)
Posted On: 04/14/2021 4:09:59 PM
NetworkNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Announces Receipt of Developmental Order for Cryogenic Probe Head
AmpliTech Group (NASDAQ: AMPG, AMPGW), a designer, developer, and manufacturer of custom and standard state-of-the-art RF (“RF”) components for commercial, SATCOM, 5G, quantum computing, space, defense and military markets, has received a developmental order for its exclusive cryogenic probe head; the order was received from Amplify My Probe Ltd. The cryogenic device, which uses AmpliTech’s innovative cryogenic low-noise amplifier technology, is designed for use in the study of materials, molecules and drugs for the treatment of diseases. A spin out from the Quantum Spin Dynamics group at the London Centre for Nanotechnology and UCLQAmplify, My Probe commercializes technology to improve the signal-to-noise ratio in EPR experiments. The Amplify My Probe team noted that the device allows the measurements of the electron paramagnetic resonance (“EPR”) experiments to proceed much faster, an estimated 100x speed up of the experiments. The announcement noted that, among possible applications, the device could be used in studies of systems with the potential to design new drugs. The announcement also stated that AmpliTech Group will be the exclusive manufacturer for the cryogenice probe head while Amplify My Probe will be sole global distributor for at least the first 18 months. “We are pleased to work with the Amplify My Probe team to help develop this innovative new product that will advance materials science and medical technology,” said AmpliTech Group CEO Fawad Maqbool in the press release. “AmpliTech Group Inc. is dedicated to be a driving force and leader in amplifier technology for communications and microwave applications that are part of everyday life around us.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
AmpliTech Group (NASDAQ: AMPG, AMPGW), a designer, developer, and manufacturer of custom and standard state-of-the-art RF (“RF”) components for commercial, SATCOM, 5G, quantum computing, space, defense and military markets, has received a developmental order for its exclusive cryogenic probe head; the order was received from Amplify My Probe Ltd. The cryogenic device, which uses AmpliTech’s innovative cryogenic low-noise amplifier technology, is designed for use in the study of materials, molecules and drugs for the treatment of diseases. A spin out from the Quantum Spin Dynamics group at the London Centre for Nanotechnology and UCLQAmplify, My Probe commercializes technology to improve the signal-to-noise ratio in EPR experiments. The Amplify My Probe team noted that the device allows the measurements of the electron paramagnetic resonance (“EPR”) experiments to proceed much faster, an estimated 100x speed up of the experiments. The announcement noted that, among possible applications, the device could be used in studies of systems with the potential to design new drugs. The announcement also stated that AmpliTech Group will be the exclusive manufacturer for the cryogenice probe head while Amplify My Probe will be sole global distributor for at least the first 18 months. “We are pleased to work with the Amplify My Probe team to help develop this innovative new product that will advance materials science and medical technology,” said AmpliTech Group CEO Fawad Maqbool in the press release. “AmpliTech Group Inc. is dedicated to be a driving force and leader in amplifier technology for communications and microwave applications that are part of everyday life around us.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)